DYAX CORP. / SHIRE PLC / Acquisition / Public / £3838m

Synopsis

Acquisition by Shire of Dyax Corp, a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products.

Principals

Dyax Corp.

Shire

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (1)

charles ruck

Partner at Latham & Watkins

Lawyer

target

124

Deals

£ 378.50 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy